Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P02533: Variant p.Tyr415His

Keratin, type I cytoskeletal 14
Gene: KRT14
Feedback?
Variant information Variant position: help 415 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Tyrosine (Y) to Histidine (H) at position 415 (Y415H, p.Tyr415His). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (Y) to medium size and polar (H) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In EBS1B. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 415 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 472 The length of the canonical sequence.
Location on the sequence: help NQEYKILLDVKTRLEQEIAT Y RRLLEGEDAHLSSSQFSSGS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         NQEYKILLDVKTRLEQEIATYRRLLEGEDAHL------SSSQFSSG--S

Mouse                         NQEYKILLDVKTRLEQEIATYRRLLEGEDAHLSSSQFSSSS

Rat                           NQEYKILLDVKTRLEQEIATYRRLLEGEDAHLSSAQFSSSS

Chicken                       NHEYRVLLDVKCRLEQEIATYRRLLEGEDAHI-------SS
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 472 Keratin, type I cytoskeletal 14
Domain 115 – 426 IF rod
Region 284 – 422 Coil 2
Modified residue 435 – 435 Phosphoserine
Helix 329 – 417



Literature citations
Genomic keratin 14 mutation detection in epidermolysis bullosa simplex.
Hut P.H.L.; van der Vlies P.; Jonkman M.F.; Shimizu H.; Buys C.H.C.M.; Scheffer H.;
Cited for: VARIANT EBS1B HIS-415; VARIANT EBS1A GLN-419; Exempting homologous pseudogene sequences from polymerase chain reaction amplification allows genomic keratin 14 hotspot analysis.
Hut P.H.L.; van der Vlies P.; Jonkman M.F.; Verlind E.; Shimizu H.; Buys C.H.C.M.; Scheffer H.;
J. Invest. Dermatol. 114:616-619(2000)
Cited for: VARIANTS EBS1A CYS-125; HIS-125 AND GLN-419; VARIANTS EBS1B ASP-247 AND HIS-415; VARIANT EBS1C LYS-422; DNA based prenatal testing for the skin blistering disorder epidermolysis bullosa simplex.
Rugg E.L.; Baty D.; Shemanko C.S.; Magee G.; Polak S.; Bergman R.; Kadar T.; Boxer M.; Falik-Zaccai T.; Borochowitz Z.; Lane E.B.;
Prenat. Diagn. 20:371-377(2000)
Cited for: VARIANTS EBS1A CYS-125 AND HIS-415; VARIANT EBS1B PRO-134;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.